Daiwa Securities Group Inc. - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01450.0%0.00%
Q2 2023$01450.0%0.00%
Q1 2023$0
-100.0%
1450.0%0.00%
Q4 2022$1
-100.0%
1450.0%0.00%
Q3 2022$2,000
+100.0%
1450.0%0.00%
Q2 2022$1,0000.0%1450.0%0.00%
Q1 2022$1,0000.0%1450.0%0.00%
Q4 2021$1,000
-50.0%
1450.0%0.00%
Q3 2021$2,0000.0%145
+101.4%
0.00%
Q2 2021$2,0000.0%720.0%0.00%
Q1 2021$2,000
+100.0%
720.0%0.00%
Q4 2020$1,000
-50.0%
72
-66.0%
0.00%
Q3 2020$2,0000.0%2120.0%0.00%
Q2 2020$2,0000.0%2120.0%0.00%
Q1 2020$2,000
-66.7%
2120.0%0.00%
Q4 2019$6,000
+20.0%
212
-10.9%
0.00%
Q3 2019$5,000
-28.6%
2380.0%0.00%
Q2 2019$7,000
+75.0%
2380.0%0.00%
Q1 2019$4,000
+33.3%
238
+51.6%
0.00%
Q4 2018$3,000
-62.5%
1570.0%0.00%
Q3 2018$8,000
+14.3%
1570.0%0.00%
Q2 2018$7,000
+16.7%
1570.0%0.00%
Q1 2018$6,0001570.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders